You have 9 free searches left this month | for more free features.

Ophthalmic Solutions

Showing 2476 - 2500 of 2,869

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Allergic Conjunctivitis Trial in Kolkata (Olopatadine Hydrochloride Ophthalmic Solution, 0.2%)

Completed
  • Allergic Conjunctivitis
  • Olopatadine Hydrochloride Ophthalmic Solution, 0.2%
  • Kolkata, India
    (unnamed)
Sep 16, 2012

Colorectal Cancer Trial in Timisoara (NER1006, Moviprep)

Completed
  • Colorectal Cancer
  • Timisoara, Romania
  • +1 more
Apr 15, 2013

Hypotension Trial in Athens (Lactated Ringer's, HES 130/0.42)

Completed
  • Hypotension
  • Lactated Ringer's
  • HES 130/0.42
  • Athens, Attiki, Greece
    2nd Department of Anesthesiology, Attikon University Hospital
Jul 12, 2013

Anti-infecting Agents, Local Trial in Toronto (2% aqueous chlorhexidine, 2% Chlorhexidine 70% isopropyl alcohol)

Unknown status
  • Anti-infecting Agents, Local
  • 2% aqueous chlorhexidine
  • 2% Chlorhexidine 70% isopropyl alcohol
  • Toronto, Ontario, Canada
    Mount Sinai Hospital
May 13, 2013

Allergic Conjunctivitis Trial (Bepreve, Placebo)

Completed
  • Allergic Conjunctivitis
  • (no location specified)
Feb 13, 2013

Dry Eye Disease Trial in Fort Worth (Difluprednate 0.05% ophthalmic emulsion, Difluprednate vehicle)

Completed
  • Dry Eye Disease
  • Difluprednate 0.05% ophthalmic emulsion
  • Difluprednate vehicle
  • Fort Worth, Texas
    Contact Alcon Call Center at 1-888-451-3937 for Trial Locations
Mar 8, 2013

Glaucoma, Ocular Hypertension Trial in Guangzhou (brimonidine tartrate/timolol fixed combination ophthalmic solution,

Completed
  • Glaucoma
  • Ocular Hypertension
  • brimonidine tartrate/timolol fixed combination ophthalmic solution
  • +3 more
  • Guangzhou, Guangdong, China
    (unnamed)
Aug 15, 2012

Dry Eye Syndromes Trial in Vienna (Chitosan- N- Acetylcysteine eye drops)

Completed
  • Dry Eye Syndromes
  • Chitosan- N- Acetylcysteine eye drops
  • Vienna, Austria
    Department of Clinical Pharmacology, Medical University of Vienn
Sep 24, 2012

Open-angle Glaucoma, Ocular Hypertension Trial (Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN

Completed
  • Open-angle Glaucoma
  • Ocular Hypertension
  • Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN Z®)
  • Latanoprost ophthalmic solution 0.005% (XALATAN®)
  • (no location specified)
May 25, 2012

Postoperative Complications, Cataract Trial in United States (Bromfenac, Placebo)

Completed
  • Postoperative Complications
  • Cataract
  • Birmingham, Alabama
  • +38 more
Mar 13, 2013

Conjunctivitis, Allergic Trial in Irvine (Bepreve, Placebo, Bepotastine Besilate)

Completed
  • Conjunctivitis, Allergic
  • Irvine, California
    ISTA Pharmaceuticals, Inc.
Feb 13, 2013

Cataract, Inflammation Trial in Berlin (Indomethacin ophthalmic solution, Ketorolac Ophthalmic Solution)

Completed
  • Cataract
  • Inflammation
  • Indomethacin ophthalmic solution
  • Ketorolac Ophthalmic Solution
  • Berlin, Germany
    Bausch & Lomb
Aug 10, 2012

Keratoconjunctivitis Sicca Trial in Conshohocken (voclosporin ophthalmic solution)

Completed
  • Keratoconjunctivitis Sicca
  • voclosporin ophthalmic solution
  • Conshohocken, Pennsylvania
    Product Investigations
Jun 21, 2012

Dry Eye Syndrome Trial in Andover (RX-10045, Vehicle for RX-10045)

Completed
  • Dry Eye Syndrome
  • Andover, Massachusetts
    Andover Eye Associates
Feb 7, 2013

Allergic Conjunctivitis Trial in Andover (RX-10045, Vehicle for RX-10045 arm)

Completed
  • Allergic Conjunctivitis
  • Andover, Massachusetts
    Andover Eye Associates
Feb 7, 2013

Cataract Trial in Irvine (Bromfenac, Placebo)

Completed
  • Cataract
  • Irvine, California
    ISTA Pharmaceuticals, Inc.
Jan 11, 2013

Noise, Death Trial in Beer-Sheva (Atropine Sulphate 1% ophthalmic drops)

Terminated
  • Noise
  • Death
  • Atropine Sulphate 1% ophthalmic drops
  • Beer-Sheva, Israel
    Ben-Gurion University of the Negev, Sial Research Center for Fam
Jul 3, 2012

Dry Eye Trial (Systane Ultra, Bausch and Lomb Sensitive Eyes)

Completed
  • Dry Eye
  • Systane Ultra
  • Bausch and Lomb Sensitive Eyes
  • (no location specified)
Sep 19, 2012

Open-angle Glaucoma, Ocular Hypertension Trial (Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN

Completed
  • Open-angle Glaucoma
  • Ocular Hypertension
  • Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN Z®)
  • Latanoprost ophthalmic solution 0.005% (XALATAN®)
  • (no location specified)
Apr 20, 2012

Eye Drops Self-instillation Trial in Bangkok (Eye Drop Guide technique, Routine self-instillation technique)

Unknown status
  • Eye Drops Self-instillation
  • Eye Drop Guide technique
  • Routine self-instillation technique
  • Bangkok, Thailand
    Faculty of Medicine, Siriraj Hospital, Mahidol University
Oct 10, 2012

Cataract Extraction Trial in Seoul (Moxifloxacin 0.5% ophthalmic solution (Vigamox), Levofloxacin 0.5% ophthalmic solution

Completed
  • Cataract Extraction
  • Moxifloxacin 0.5% ophthalmic solution (Vigamox)
  • Levofloxacin 0.5% ophthalmic solution (Cravit)
  • Seoul, Korea, Republic of
    (unnamed)
Jul 19, 2012

Normal Tension Glaucoma Trial in Seoul (Brimonidine/Timolol mixed combination, Timolol)

Unknown status
  • Normal Tension Glaucoma
  • Brimonidine/Timolol mixed combination
  • Timolol
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Oct 3, 2011

Bowel Preparation for Colonoscopy Trial in Sabadell (behavioral, other, dietary supplement, drug)

Unknown status
  • Bowel Preparation for Colonoscopy
  • Education
  • +4 more
  • Sabadell, Barcelona, Spain
    Hospital de Sabadell
May 9, 2013

Doppler Curve of Ophthalmic Arteries in Glaucoma Patients

Completed
  • Open-angle Glaucoma
  • Low Tension Glaucoma
    • Leuven, Belgium
      Department of Ophthalmology, UZLeuven
    Feb 5, 2013

    Erythropoietin and VEGF in Type 2 Diabetes Proliferative

    Completed
    • Diabetic Retinopathy
      • Brescia, Italy
        Spedali Civili di Brescia
      Jun 5, 2013